These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28448952)

  • 21. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?
    Pea F; Viale P
    Crit Care; 2009; 13(3):214. PubMed ID: 19519961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sepsis.
    Bender BS
    Clin Geriatr Med; 1992 Nov; 8(4):913-24. PubMed ID: 1423143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early use of polymyxin B in sepsis].
    Nalesso F
    G Ital Nefrol; 2012; 29 Suppl 54():S64-6. PubMed ID: 22388833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
    Ronco C
    Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy.
    Vazquez-Grande G; Kumar A
    Semin Respir Crit Care Med; 2015 Feb; 36(1):154-66. PubMed ID: 25643278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations in the therapy of septic shock.
    Karakusis PH
    Med Clin North Am; 1986 Jul; 70(4):933-44. PubMed ID: 3520187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Septic shock; current pathogenetic concepts from a clinical perspective.
    Tsiotou AG; Sakorafas GH; Anagnostopoulos G; Bramis J
    Med Sci Monit; 2005 Mar; 11(3):RA76-85. PubMed ID: 15735579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
    Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
    Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of shock caused by bacterial infections.
    Weil MH; Shubin H
    Calif Med; 1973 Nov; 119(5):7-13. PubMed ID: 4755702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid Diagnostics for Blood Cultures: Supporting Decisions for Antimicrobial Therapy and Value-Based Care.
    Wolk DM; Johnson JK
    J Appl Lab Med; 2019 Jan; 3(4):686-697. PubMed ID: 31639736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriateness of Broad Spectrum Antibiotics for Severe Sepsis and Septic Shock in the Emergency Department.
    Worapratya P; Joraluck J; Wanjaroenchaisuk A; Wuthisuthimethawee P
    J Med Assoc Thai; 2016 May; 99(5):477-83. PubMed ID: 27501600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the diagnostic process on the accuracy of source identification and time to antibiotics in septic emergency department patients.
    Uittenbogaard AJ; de Deckere ER; Sandel MH; Vis A; Houser CM; de Groot B
    Eur J Emerg Med; 2014 Jun; 21(3):212-9. PubMed ID: 23636023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studying the levels of endotoxemia in meningococcal sepsis. Its relations to pregnancy and antibiotic treatment].
    Loscertales Abril M; Ruiz Extremera A; Rodríguez Contreras R; Galvez Vargas R; Gómez Vida J; Ibarra de la Rosa I; del Castillo Aguas G; Molina Font JA
    An Esp Pediatr; 1991 May; 34(5):355-9. PubMed ID: 1883109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endotoxin in the clinic and in experiments].
    Rumiantsev AG; Kasatkin VN; Kanaeva ES
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):110-4. PubMed ID: 7941855
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: where is the gap?
    Capp R; Chang Y; Brown DF
    J Emerg Med; 2011 Dec; 41(6):573-80. PubMed ID: 21371846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cellular basis of septic shock.
    Sommers MS
    Crit Care Nurs Clin North Am; 2003 Mar; 15(1):13-25. PubMed ID: 12597036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of neonates with culture-proven bloodstream infection who have low levels of C-reactive protein (≦10 mg/L).
    Lai MY; Tsai MH; Lee CW; Chiang MC; Lien R; Fu RH; Huang HR; Chu SM; Hsu JF
    BMC Infect Dis; 2015 Aug; 15():320. PubMed ID: 26259626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoproterenol in the treatment of shock due to bacteremia with gram-negative pathogens.
    Kardos GG
    N Engl J Med; 1966 Apr; 274(16):868-73. PubMed ID: 17926865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute pylephlebitis following gastrointestinal infection: an unrecognized cause of septic shock.
    Altamirano J; Zapata L; Poblano M; Rodríguez A; Camargo L; Martínez B; Bataller R
    South Med J; 2010 Sep; 103(9):956-9. PubMed ID: 20689494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.